194.55

0.23% -0.4085

Becton Dickinson Co (BDX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BDX Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$194.96

Aprire:

$195.21

Volume 24 ore:

1.25M

Relative Volume:

0.43

Capitalizzazione di mercato:

$55.79B

Reddito:

$21.39B

Utile/perdita netta:

$1.59B

Rapporto P/E:

34.99

EPS:

5.56

Flusso di cassa netto:

$2.55B

1 W Prestazione:

+12.82%

1M Prestazione:

+10.53%

6M Prestazione:

-13.56%

1 anno Prestazione:

-17.68%

Intervallo 1D:

$193.94

$196.18

Intervallo di 1 settimana:

$184.21

$196.18

Portata 52W:

$163.33

$251.99

Becton Dickinson Co Stock (BDX) Company Profile

Nome

Becton Dickinson Co

Settore

Healthcare (1164)

Industria

Medical Instruments & Supplies (58)

Telefono

(201) 847-6800

Indirizzo

ONE BECTON DR, FRANKLIN LAKES

Dipendente

74,000

Cinguettio

@BDandCo

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

BDX's Discussions on Twitter

Confronta BDX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BDX Becton Dickinson Co	194.63	55.18B	21.39B	1.59B	2.55B	5.56
ISRG Intuitive Surgical Inc	481.31	169.15B	9.15B	2.61B	1.99B	7.17
RMD Resmed Inc	289.71	41.63B	5.15B	1.40B	1.65B	9.51
ALC Alcon Inc	86.49	41.88B	9.93B	1.12B	1.58B	2.25
WST West Pharmaceutical Services Inc	244.01	17.28B	2.90B	467.20M	306.90M	6.37

Becton Dickinson Co Stock (BDX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-05-22	Downgrade	Citigroup	Buy → Neutral
2025-05-02	Downgrade	Goldman	Buy → Neutral
2025-05-02	Downgrade	Piper Sandler	Overweight → Neutral
2025-05-02	Downgrade	Raymond James	Outperform → Mkt Perform
2025-05-01	Downgrade	BofA Securities	Buy → Neutral
2025-05-01	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-05-01	Downgrade	William Blair	Outperform → Mkt Perform
2024-10-01	Aggiornamento	Citigroup	Neutral → Buy
2024-05-30	Iniziato	Goldman	Buy
2023-07-24	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-05-30	Ripresa	Morgan Stanley	Overweight
2023-05-05	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-04-12	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2023-01-03	Aggiornamento	BofA Securities	Neutral → Buy
2022-12-12	Aggiornamento	Citigroup	Sell → Neutral
2022-07-11	Downgrade	Citigroup	Neutral → Sell
2022-06-24	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2022-03-18	Ripresa	Raymond James	Mkt Perform
2022-03-02	Ripresa	BofA Securities	Neutral
2021-12-08	Downgrade	Piper Sandler	Overweight → Neutral
2021-08-06	Downgrade	JP Morgan	Overweight → Neutral
2021-05-25	Iniziato	Barclays	Equal Weight
2020-12-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-12-15	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-07-09	Aggiornamento	Barclays	Equal Weight → Overweight
2020-06-01	Ripresa	Goldman	Buy
2020-03-05	Iniziato	Citigroup	Neutral
2020-02-07	Downgrade	Cowen	Outperform → Market Perform
2020-02-07	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2020-02-07	Downgrade	Raymond James	Strong Buy → Outperform
2020-02-06	Downgrade	Cowen	Outperform → Market Perform
2020-01-08	Downgrade	Barclays	Overweight → Equal Weight
2019-05-13	Aggiornamento	Barclays	Equal Weight → Overweight
2018-12-07	Iniziato	Deutsche Bank	Buy
2018-10-16	Iniziato	Barclays	Equal Weight
2018-06-21	Aggiornamento	JP Morgan	Neutral → Overweight
2018-04-10	Aggiornamento	Citigroup	Neutral → Buy
2018-01-19	Ripresa	BofA/Merrill	Buy
2018-01-05	Aggiornamento	Citigroup	Sell → Neutral
2018-01-05	Iniziato	KeyBanc Capital Mkts	Overweight
2018-01-03	Iniziato	Evercore ISI	Outperform
2017-12-29	Reiterato	Deutsche Bank	Buy

Mostra tutto

Becton Dickinson Co Borsa (BDX) Ultime notizie

08:00 AM

Clinical Microbiology Market to Reach $6.9 Billion by 2029, Driven by Advanced Diagnostics and Regulatory Demand | MarketsandMarkets™. - GlobeNewswire Inc.

08:00 AM

Aug 12, 2025

Diamond Hill Capital's Strategic Moves: Significant Reduction in Becton Dickinson & Co - Yahoo Finance

Aug 12, 2025

Aug 11, 2025

Director’s Bold Move: A Million-Dollar Bet on Becton Dickinson! - TipRanks

Aug 11, 2025

Judge OKs Becton Dickinson's $9M Investor Settlement - Law360

Aug 11, 2025

Aug 10, 2025

4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential - 24/7 Wall St.

Aug 10, 2025

BD Careers | Jobs at BD | We are the Makers of Possible - Becton Dickinson

Aug 10, 2025

Aug 09, 2025

Earnings Beat: Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - 富途牛牛

Aug 09, 2025

Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200 - 富途牛牛

Aug 09, 2025

Aug 08, 2025

Director Makes Significant Move with Becton Dickinson Stock! - TipRanks

Aug 08, 2025

J.P. Morgan Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $190 - 富途牛牛

Aug 08, 2025

A Quick Look at Today's Ratings for Becton Dickinson & Co(BDX.US), With a Forecast Between $183 to $200 - 富途牛牛

Aug 08, 2025

Becton Dickinson: Wells Fargo maintains Equal-Weight, raises PT to $184 from $172. - AInvest

Aug 08, 2025

Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call Transcript - Insider Monkey

Aug 08, 2025

Becton Dickinson price target raised to $200 from $185 at Piper Sandler - TipRanks

Aug 08, 2025

Piper Sandler raises Becton Dickinson stock price target to $200 on earnings beat - Investing.com

Aug 08, 2025